Congratulations to the Recipients of our Travel Grants to Attend AACR 2016!

Jai-Hyun Kim, Research Scientist
Orange CA, USA

Melissa LaBonte Wilson, Lecturer
Belfast, United Kingdom

Rahul Gosavi, Senior Research Fellow
Mumbai, India

Amanda Muñoz, Graduate Research Assistant
San Antonio TX, USA

Isaac Harris, Postdoctoral Fellow
Brookline MA, USA
Brian Booth, Research Assistant Professor
Clemson SC, USA

Hee Jin Lee, Senior Clinical Instructor
Seoul, Republic of Korea

Wadie Mahauad-Fernandez, Graduate Research Assistant
Iowa City IA, USA

Luis Reyes, PhD student
Mexico City, Mexico

Sarah Maritan, Undergraduate student
Kingston, Canada

Terms and Conditions: See Details

  1. Travel grants will be awarded to support attendance at AACR 2016 held in New Orleans, LA , April 16-20, 2016 and no other event.
  2. All applications must be submitted to Bio-Techne via the online application between Dec 15, 2015 and Feb 8, 2016.
  3. Any researcher from an academic or non-profit institution is eligible to apply (technicians, PhD/graduate students, post-docs, principal investigators).
  4. Authorship on an abstract at AACR 2016 is not required.
  5. Applicants must complete the application form in full.
  6. Travel grants will not be awarded to employees of for-profit organizations (i.e. biotech or pharmacological companies).
  7. Travel grant recipients will be determined via a random drawing by Bio-Techne.
  8. The recipients will be contacted by email on Feb 16, 2016 and also announced online.
  9. Travel grants will be paid to the laboratory of the award recipient's principal investigator via the parent university or institution. If paid directly to the PI of the lab, taxes may apply.
  10. Proof of attendance at AACR 2016 will be required prior to travel grant payment.
  11. By submitting this application, you agree to receive information from Bio-Techne brands (R&D Systems, Tocris Bioscience and Novus Biologicals), including distributors. Your information will never be sold or used by a third party. See our complete Privacy Policy for more information.


Thank you

Thank you

To whom it may concern:

I would like to apply for Travel Grants to Attend AACR Annual Meeting 2016 sponsored by R&D systems.

I come to Mayo Clinic to develop my reserch. My interest is hepatobiliary disease, particularly hepatocellular carcinoma and cholangiocarcinoma. Now I am conducting research regarding FGFR2 translocation in cholangiocarcinoma in Dr. Lewis R. Roberts lab, and would like to attent ACCR Annual Meeting 2016. I would relly appreciate if you can give me the travel grant for me.

Thank you so much.

Best Regards,

Katsuyuki Miyabe  

Dear Bio-Techne team,

Thank you so much for your travel grant offer.

I am a PhD Student in the department of medical oncology at VUmc Cancer Center Amsterdam, working towards combining Natural killer cells with therapeutic monoclonal antibodies in the treatment of solid tumors. I would like to attend the AACR meeting in 2016. Your travel funding will be of great help for me to attend AACR.

Kind regards

John Veluchamy

Dear Bio-Techne team,

I would like to express my gratitude to offer the travel awards for AACR annual conferences.

I am Dr. Khyati Shah, a postdoc fellow in Dr. Sourav Bandyopadhyay lab's in Helen Diller Family Comprehensive Cancer Center at UCSF. At HDFCC, we work at an exciting interphase of mapping genomics and proteomics of tumor cells for therapeutically meaningful discovery. We are using the Luminex platform to dissect the proteomic of receptor tyrosine networking in case of third-generation EGFR resistance. Using this platform, we have identified the novel synthetic lethality to kill this resistant tumor cells. I am extremely fortunate to work on this exciting project and contribution of R&D system to make this project faster. We usually interact with R&D system regularly for customized Luminex kits and other reagents. I and my team are regular visitors at Vendor display at AACR annual and other conferences.

I would be really delighted to have this financial support from R&D system. I look forward to further collaboration.


Dear Sirs,

I would like to express my gratitude for your travel grant offer.

I am a post doc fellow in Dr. Caroline Alexander lab at the McArdle Laboratory for Cancer Research in Madison, WI. Our lab is studying aspects of mammary gland biology and neoplasia using transgenic mouse models. Particularly, I am working on the discovery of the molecular and cellular mechanism that underlies the tumor resistance phenotype illustrated by mice with mutation in the heparan sulfate proteoglycan, syndecan-1 (Sdc1). Recently we reported that loss of Sdc1 disrupts a newly identified fat layer (dermal white adipose tissue) in the mammalian skin resulting cold stress, complex metabolic pathology and eventually tumor resistance.

I would like to attend the AARC meeting in 2016. Your travel grant would be a great help for me to present my research in front of our cancer biologist society.

Thanks in advance!

Best Regards,

Ildiko Kasza, PhD





Dear R&D Systems Staff,

Thank you for the opportunity to apply for this travel grant.  I look forward to presenting my research on Mdm2 and its role in cancer associated osteolytic disease at the 2016 AACR conference.

Best Regards,

David Olivos, PhD

Thank you for your generous support.

Thank you for the sponsorship. The most trusted brand for antibodies and other reagents- R and D systems,  best gift for intrested scientists.


Dear Sir. Madam

My name is Majed from Iraq, I want to cooperate with your organization.


Majed H. Mohammed Ph.D.


Hi! My name is Edwin Velazquez and I’m a biochemical engineer from La Paz B.C.S., Mexico, currently enrolled in a microbiology and molecular biology master’s program here in USA. I have submitted our work for the next AACR meeting which consist in anovel immunotherapeutyc marker for lungcancer. The work has been accepted and I'm going to present it. We are grateful for people who sponsor research, specially cancer research. I’m looking to get in a Ph. D. program to actively contribute in biomedical research and help people of Latin America through cancer research, in the future as a researcher I would like to start a biomedical company to boost Latin America to be self-reliant in immunotherapy making medicine more affordable for people.

I am a researcher at Duke University, and our lab is studying the effect of antioxidants (superxide dismutase mimics) on oxidative stress-mediated breast cancer growth as a novel therapeutics. 

I would like to attend the AARC meeting in 2016. Your travel grant would be a great help for me to attend this meeting and reconnect with our cancer biologist society.

Thank you,


Dear Sir,

I am  PhD scholar in National Institute of Mental Health and Neurosciences...I would like to attaend the AACR meeting in 2016.....i am working in the field of cancer genetics...our lab mainly focuses on molecular mechanisms of glioma.I am working on the downregulation of hTERT in glioblastoma cell lines using knockdown approches...I would like to present my work in AACR Annual meeting 2016.....Your travel grant would be a financial support for me to attend the  AACR Annual meeting 2016 and also helps me to establish a scientific relationship with the eminants working in the cancr field..It also provides me an oppurtunity to intorduce and collabarates  R&D systems with our institute.





Submitted by Nathalie Madern on Tuesday, 1/19/2016 - 03:46

I am a post doctoral fellow in OUHSC. My research interest to test the effects of drugd in different pre-clinical model and further decipher the mechanism of the drug in in vitro. I would like to apply for Travel Grants to attend AACR Annual Meeting 2016.  I would really appreciate if you can give me the travel grant for me.

Thank you so much.

Best Regards,

Gaurav Kumar

Dear Bio-Techne team,

First of all I would like to pay my sincere thanks for your generous support. I am a postdoctoral fellow and have experimented products from R & D systems mostly “interleukins” and published in peer reviewed journals. At AACR vendors display by R & D system is my first preference always to get information about new products and customer support. My research interest is in genomics such as next generation (targeted exome_seq and RNA_seq) sequencing and genome editing. I want to present poster in AACR annual meeting 2016. However my abstract has already been accepted. I am looking forward for travel grant to attend this meeting.

Thanks in anticipation

Santosh Yadav Ph.D

Dear Bio-Techne Team,


I am a PhD scholar working towards investigating the role of PARP-1 in cisplatin resistance in cervical cancer. Currently we are studying the effect of PARP-1 inhibition on cisplatin sensitivity in vitro and this study is planned to correlate the in vitro results with actual scenario in cisplatin treated cervix cancer patients, with the aim to exploit potential of PARP-1 to act as a biomarker for predicting probability of relapse. We submitted an abstract with data collected from a part of in vitro study that has been selected for poster presentation at AACR on Monday Apr 18, 2016.

This financial grant will be a great and kind help to attend and present my work at AACR annual meeting 2016.

Thanks and Regards,

Minakshi Mann,

PhD Scholar,

Dept. of Medical Oncology, 



Jimenez-Sainz J. and Jensen R.

The BRCA2 (Breast Cancer Susceptibility 2) gene is a caretaker of genome integrity.  Germline mutations in BRCA2 predispose to a high risk for ovarian and breast cancer.  The BRCA2 protein plays an important role in repair of DNA double-strand breaks (DSBs) by homologous recombination.  BRCA2 dysfunction results in genome instability including chromosome aberrations and an abnormal number of centrosomes.  Centrosome amplification is a hallmark of tumors from BRCA2 mutation carriers and may be responsible for the origin of chromosome missegregation at mitosis and DNA aneuploidy found in these tumors.  However, it remains an open question how BRCA2 regulates centrosome duplication and the consequences for tumor initiation and progression.  Here, we present the generation of an isogenic inducible BRCA2 human cell line providing a model to study acute loss of the BRCA2 protein.  We plan to measure centrosome number and how BRCA2 regulates the centrosome duplication checkpoint with the end goal of understanding tumor initiation and maintenance in BRCA2 mutation carriers.